<DOC>
	<DOCNO>NCT00741208</DOCNO>
	<brief_summary>The purpose study determine dietary supplementation soy isoflavones persistent asthma improve airway reactivity determine PC20 methacholine .</brief_summary>
	<brief_title>Modification Asthma With Soy Isoflavone</brief_title>
	<detailed_description>Asthma complex disease whose prevalence severity determine multiple genetic environmental factor . The prevalence asthma increase past decade . Although causal relationship proven , change dietary practice parallel increase asthma prevalence . Several survey find association reduce lung function decrease consumption antioxidant , flavonoid , essential vitamin variety respiratory condition include asthma . These finding suggest diet may factor impact asthma clinical manifestation . Higher dietary consumption soy isoflavones associate decrease self-report cough allergic respiratory symptom . Our group report inverse relationship dietary intake soy isoflavone genistein asthma severity . In addition , recently demonstrate genistein inhibits synthesis cysteinyl-leukotrienes eosinophil block p38-dependent activation 5-lipoxygenase , provide plausible cellular mechanism benefit soy isoflavones asthma . We also document dietary soy isoflavone supplementation asthma patient inhibited eosinophil cysteinyl-leukotriene synthesis decrease exhaled nitric oxide , indicator eosinophilic airway inflammation . Our overall long-term goal translate epidemiological mechanistic finding human disease determine whether dietary soy isoflavones clinical role asthma . We propose clinical study power detect improvement lung function first stop achieve goal . Our hypothesis dietary supplementation isoflavones improve lung function , reduce symptom , decrease airway inflammation asthma . To test , conduct randomize placebo-controlled , cross-over study soy isoflavone supplementation patient persistent asthma .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>18 year age old ; Physician diagnose asthma ; Positive methacholine bronchoprovocation test ( 20 % fall FEV1 le 8 mg/ml ) past 3 year ; Smoking Status : nonsmoker 6 month longer less 10 packyear cumulative smoking history . Pulmonary function FEV1 &lt; 70 % predicted prebronchodilator ; Other major chronic illness : condition judgement athe principle investigator would interfere participation study history physician diagnosis COPD , emphysema , chronic bronchitis ; Medication use : current consumption soy isoflavone supplement oral corticosteroid use within past 6 month OR use investigational treatment within previous 30 day ; Drug allergy : know adverse reaction genistein , phytoestrogens , soy product ; Females childbearing potential : pregnant lactate woman appropriate ago report possibility pregnancy time enrollment screen participate pregnant ; Nonadherence : inability unwillingness provide inform consent inability swallow study medication inability perform baseline measurement completion few 5 7 day screen period diary entry inability contact telephone ; Other exclusion : recent asthma exacerbation ( within 6 week ) recent upper respiratory tract infection ( within 2 week ) change diet past 1 month expect change diet ( example weight loss diet ) 6 week study period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>asthma</keyword>
	<keyword>soy isoflavone</keyword>
	<keyword>genistein</keyword>
	<keyword>soy</keyword>
</DOC>